Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis

Eye

Volumn 22, Issue 9, 2008, Pages 1201-1202

  Backhouse, O ^a   Bhan, K J ^b   Bishop, F ^a  

^a LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^b Yorkshire Deanery   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CLINDAMYCIN; IMMUNOGLOBULIN M; PREDNISOLONE; TRIAMCINOLONE ACETONIDE;

ADULT; CASE REPORT; CAUCASIAN; CLINICAL FEATURE; DISEASE SEVERITY; DRUG DOSE REDUCTION; FLUORESCENCE ANGIOGRAPHY; HUMAN; LETTER; MALE; METAMORPHOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTICAL COHERENCE TOMOGRAPHY; PATIENT REFERRAL; PHLEBITIS; RETINA FOVEA; SCAR FORMATION; TOXOPLASMOSIS; UVEITIS; VISUAL ACUITY; VITRECTOMY;

EID: 52149097386     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2008.5     Document Type: Letter

References (9)

1. Aggio FB, Muccioli C, Belfort Jr R. Intravitreal triamcinolone acetonide as an adjunct in the treatment of severe ocular toxoplasmosis. Eye 2006; 20(9): 1080-1082.
2. Sabates R, Pruett RC, Brockhurst RJ. Fulminant ocular toxoplasmosis. Am J Ophthalmol 1981; 92: 497-503.
3. O'Connor GF, Frenkel JK. Editorial: Dangers of steroid treatment in toxoplasmosis. Periocular injections and systemic therapy. Arch Ophthalmol 1976; 94: 213.
4. Nozik RA. Results of treatment of ocular toxoplasmosis with mjectable steroids. Trans Am Acad Ophthalmol Otolaryngol 1977; 83: 811-818.
5. Benson MT, Parsons MA, Talbot JF, Rennie IG. Aggressive toxoplasma retinitis. Acta Ophthalmol 1992; 70: 795-800.
6. Bosch-Driessen EH, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: Clinical features and prognosis of 154 patients. Ophthalmology 2002; 109: 869-878.
7. Nobrega MJ, Rosa EL. Toxoplasmosis retinochoroiditis after photodynamic therapy and intravitreal triamcinolone for a supposed choroidal neovascularisation. Arq Bras Oftalmol 2007; 70(1): 157-160.
8. Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol 2002; 134: 102-114.
9. Bosch-Driessen EH, Rothova A. Sense and nonsense of corticosteroid administration in the treatment of ocular toxoplasmosis. Br J Ophthalmol 1998; 82: 858-860.